Bolt Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.46

-0.12 (-3.35%)

As of Sep 28, 10:41 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +662.1% upside

Low Target $21.16

Average Target $26.37

High Target $30.50

Current Price $3.46

Current
$3.46

Target
$26.37

$21.16 $26.37 avg $30.50

Scenario Analysis

Bear Case

$21.16

511.5%

Low target

Base Case

$26.37

+662.1%

Avg target

Bull Case

$30.50

+781.5%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$7.20

-51.9% from high

52-Week Low

$3.10

+11.6% from low

Target vs 52W High

$26.37

+266.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%